Investment management company Conestoga Capital Advisors, LLC sold 3,896,749 shares of CCC Intelligent Solutions Holdings, valued at $37.69 million. Post-trade,
Hormel Foods Sales, LLC is recalling over 4.8 million pounds of HORMEL FIRE BRAISED products due to potential metal contamination.
Plynk, a digital investing app, has launched a program called Plynk Serve: Military to help veterans build wealth through stocks
Waters Corporation, a global leader in analytical instruments, is set to announce its fiscal Q3 earnings for 2025 on Nov.
The REX-Osprey XRP ETF (XRPR) has exceeded $100 million in assets under management in just one month since its launch,
The Bull Strangle Newsletter offers a trading strategy with a 76% win rate and has outperformed the S&P 500 by
Investor Kevin O’Leary believes CEOs aren’t too worried about trade tensions, as they expect tariffs to ease in the next
Avacta Therapeutics presented preclinical data on its dual payload technology at a cancer conference, showcasing its ability to deliver two
Medical Properties Trust (NYSE: MPW) has faced challenges with bankrupt tenants, leading to two major dividend cuts totaling over 70%,
Summary: Saving for retirement can be challenging, especially with a low income and immediate financial priorities. Catch-up contributions allow individuals
Fluence Energy Inc. (NASDAQ:FLNC) saw a 21.77% surge on Friday, closing at $19.52 per share as investors sought out AI-related
Grindr Inc. (NYSE:GRND) saw a significant 18.86% surge in its stock price on Friday, closing at $15.06 per share. This
Garrett Motion Inc. (NASDAQ:GTX) saw a surge in stock price to a new all-time high on Friday following impressive earnings
AlphaTON Capital Corp and its subsidiary, Tarus Therapeutics, present a new poster at the AACR-NCI-EORTC International Conference on Molecular Targets
BridgeBio Oncology Therapeutics, Inc. announced promising preclinical data on BBO-10203, showing it blocks RAS-mediated activation of PI3Kα without affecting glucose
This week saw eleven crypto companies raise $99.6 million, pushing total funding for the industry to nearly $22 billion in
Cullinan Therapeutics presented new preclinical data for CLN-978, a CD19xCD3 bispecific T cell engager, at the American College of Rheumatology
Sobi North America presented data at the ACR Convergence 2025 meeting showcasing the positive impact of their immunology portfolio on
Kyverna Therapeutics announced positive results from a Phase 1 trial of KYV-101 in patients with difficult-to-treat rheumatoid arthritis. The treatment
CoreWeave (CRWV) has seen a 207.5% increase in stock price since its IPO in March, indicating strong growth potential. In
Novartis will present late-breaking data from Phase III trials for ianalumab in Sjögren’s disease and biomarker data for rapcabtagene autoleucel
AutoZone reported an $80 million non-cash charge due to tariffs, which is expected to increase to $120 million in the
The scariest horrors in life don’t come in costumes – they slash your wallet when you least expect it. Business
Phathom Pharmaceuticals announced positive results from a Phase 3 trial showing VOQUEZNA provided rapid and sustained relief of nighttime GERD
Broadcom Inc (AVGO) is experiencing a surge in stock performance, up 53% year-to-date, outperforming Nvidia (NVDA) and the Nasdaq Composite
